Skip to main content
In stock | Cellular Therapy

Lifileucel

Oncology Type Solid Tumour
Drug Class / Mechanism Autologous Tumour-Infiltrating Lymphocyte (TIL) Therapy
No Image
Description

Lifileucel is classified as an Autologous Tumour-Infiltrating Lymphocyte (TIL) Therapy, sourced for use within our Cellular Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Cellular Therapy
Oncology Type Solid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3